Proteotyping of Clostridioides difficile as Alternate Typing Method to Ribotyping Is Able to Distinguish the Ribotypes RT027 and RT176 From Other Ribotypes. 2019

Matthias F Emele, and Felix M Joppe, and Thomas Riedel, and Jörg Overmann, and Maja Rupnik, and Paul Cooper, and R Lia Kusumawati, and Fabian K Berger, and Friederike Laukien, and Ortrud Zimmermann, and Wolfgang Bohne, and Uwe Groß, and Oliver Bader, and Andreas E Zautner
Institut für Medizinische Mikrobiologie, Universitätsmedizin Göttingen, Göttingen, Germany.

Clostridioides difficile, a Gram-positive spore-forming bacterium, is the leading cause of nosocomial diarrhea worldwide and therefore a substantial burden to the healthcare system. During the past decade, hypervirulent PCR-ribotypes (RT) e.g., RT027 or RT176 emerged rapidly all over the world, associated with both, increased severity and mortality rates. It is thus of great importance to identify epidemic strains such as RT027 and RT176 as fast as possible. While commonly used diagnostic methods, e.g., multilocus sequence typing (MLST) or PCR-ribotyping, are time-consuming, proteotyping offers a fast, inexpensive, and reliable alternative solution. In this study, we established a MALDI-TOF-based typing scheme for C. difficile. A total of 109 ribotyped strains representative for five MLST clades were analyzed by MALDI-TOF. MLST, based on whole genome sequences, and PCR-ribotyping were used as reference methods. Isoforms of MS-detectable biomarkers, typically ribosomal proteins, were related with the deduced amino acid sequences and added to the C. difficile proteotyping scheme. In total, we were able to associate nine biomarkers with their encoding genes and include them in our proteotyping scheme. The discriminatory capacity of the C. difficile proteotyping scheme was mainly based on isoforms of L28-M (2 main isoforms), L35-M (4 main isoforms), and S20-M (2 main isoforms) giving rise to at least 16 proteotyping-derived types. In our test population, five of these 16 proteotyping-derived types were detected. These five proteotyping-derived types did not correspond exactly to the included five MLST-based C. difficile clades, nevertheless the subtyping depth of both methods was equivalent. Most importantly, proteotyping-derived clade B contained only isolates of the hypervirulent RT027 and RT176. Proteotyping is a stable and easy-to-perform intraspecies typing method and a promising alternative to currently used molecular techniques. It is possible to distinguish the group of RT027 and RT176 isolates from non-RT027/non-RT176 isolates using proteotyping, providing a valuable diagnostic tool.

UI MeSH Term Description Entries

Related Publications

Matthias F Emele, and Felix M Joppe, and Thomas Riedel, and Jörg Overmann, and Maja Rupnik, and Paul Cooper, and R Lia Kusumawati, and Fabian K Berger, and Friederike Laukien, and Ortrud Zimmermann, and Wolfgang Bohne, and Uwe Groß, and Oliver Bader, and Andreas E Zautner
March 2019, Scientific reports,
Matthias F Emele, and Felix M Joppe, and Thomas Riedel, and Jörg Overmann, and Maja Rupnik, and Paul Cooper, and R Lia Kusumawati, and Fabian K Berger, and Friederike Laukien, and Ortrud Zimmermann, and Wolfgang Bohne, and Uwe Groß, and Oliver Bader, and Andreas E Zautner
January 2021, Frontiers in cellular and infection microbiology,
Matthias F Emele, and Felix M Joppe, and Thomas Riedel, and Jörg Overmann, and Maja Rupnik, and Paul Cooper, and R Lia Kusumawati, and Fabian K Berger, and Friederike Laukien, and Ortrud Zimmermann, and Wolfgang Bohne, and Uwe Groß, and Oliver Bader, and Andreas E Zautner
August 2021, Antibiotics (Basel, Switzerland),
Matthias F Emele, and Felix M Joppe, and Thomas Riedel, and Jörg Overmann, and Maja Rupnik, and Paul Cooper, and R Lia Kusumawati, and Fabian K Berger, and Friederike Laukien, and Ortrud Zimmermann, and Wolfgang Bohne, and Uwe Groß, and Oliver Bader, and Andreas E Zautner
March 2021, Diagnostic microbiology and infectious disease,
Matthias F Emele, and Felix M Joppe, and Thomas Riedel, and Jörg Overmann, and Maja Rupnik, and Paul Cooper, and R Lia Kusumawati, and Fabian K Berger, and Friederike Laukien, and Ortrud Zimmermann, and Wolfgang Bohne, and Uwe Groß, and Oliver Bader, and Andreas E Zautner
April 2019, Anaerobe,
Matthias F Emele, and Felix M Joppe, and Thomas Riedel, and Jörg Overmann, and Maja Rupnik, and Paul Cooper, and R Lia Kusumawati, and Fabian K Berger, and Friederike Laukien, and Ortrud Zimmermann, and Wolfgang Bohne, and Uwe Groß, and Oliver Bader, and Andreas E Zautner
August 2020, Journal of microbiological methods,
Matthias F Emele, and Felix M Joppe, and Thomas Riedel, and Jörg Overmann, and Maja Rupnik, and Paul Cooper, and R Lia Kusumawati, and Fabian K Berger, and Friederike Laukien, and Ortrud Zimmermann, and Wolfgang Bohne, and Uwe Groß, and Oliver Bader, and Andreas E Zautner
April 2022, Microbial genomics,
Matthias F Emele, and Felix M Joppe, and Thomas Riedel, and Jörg Overmann, and Maja Rupnik, and Paul Cooper, and R Lia Kusumawati, and Fabian K Berger, and Friederike Laukien, and Ortrud Zimmermann, and Wolfgang Bohne, and Uwe Groß, and Oliver Bader, and Andreas E Zautner
June 2020, Anaerobe,
Matthias F Emele, and Felix M Joppe, and Thomas Riedel, and Jörg Overmann, and Maja Rupnik, and Paul Cooper, and R Lia Kusumawati, and Fabian K Berger, and Friederike Laukien, and Ortrud Zimmermann, and Wolfgang Bohne, and Uwe Groß, and Oliver Bader, and Andreas E Zautner
February 2020, Emerging infectious diseases,
Matthias F Emele, and Felix M Joppe, and Thomas Riedel, and Jörg Overmann, and Maja Rupnik, and Paul Cooper, and R Lia Kusumawati, and Fabian K Berger, and Friederike Laukien, and Ortrud Zimmermann, and Wolfgang Bohne, and Uwe Groß, and Oliver Bader, and Andreas E Zautner
January 2020, Emerging microbes & infections,
Copied contents to your clipboard!